Showing results (61-70 of 817) with videos related to
Sort By:
Pageof 82
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 21, 2023
C3G and Ig-MPGN-treatment standardMarina Noris, Giuseppe RemuzziNephron|December 23, 2014
Effects of MCP-1 inhibition by bindarit therapy in a rat model of polycystic kidney diseaseCarlamaria Zoja, Daniela Corna, Monica Locatelli, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 5, 2010
Burden of CKD, proteinuria, and cardiovascular risk among Chinese, Mongolian, and Nepalese participants in the International Society of Nephrology screening programsSanjib Kumar Sharma, Hequn Zou, Ariunaa Togtokh, et al.American Journal of Physiology. Renal Physiology|August 14, 2009
Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetesElena Gagliardini, Daniela Corna, Carla Zoja, et al.Annali Dell'Istituto Superiore Di Sanita|March 25, 2011
Why rare diseases?Giuseppe Remuzzi, Arrigo SchieppatiCurrent Opinion in Nephrology and Hypertension|October 10, 2018
Mesenchymal stromal cells in kidney transplantationFederica Casiraghi, Giuseppe RemuzziKidney International. Supplement|August 20, 2005
Chronic renal diseases as a public health problem: epidemiology, social, and economic implicationsArrigo Schieppati, Giuseppe RemuzziKidney International|October 31, 2020
Atypical hemolytic uremic syndrome associated with a factor B genetic variant and fluid-phase complement activation: an exception to the rule?Marina Noris, Giuseppe RemuzziKidney International|October 20, 2024
Looking into the cholesterol crystal ball: is complement the answer?Marina Noris, Giuseppe RemuzziPlos Medicine|September 21, 2016
Interplay between Diagnostic Criteria and Prognostic Accuracy in Chronic Kidney DiseaseGiuseppe Remuzzi, Richard GlassockPageof 82